Dr. Jason E. Berilgen

Jason Ertan Berilgen, MD, graduated Magna Cum Laude with a bachelor’s degree in physics from Washington University in St. Louis, Missouri. He earned his Doctor of Medicine from Baylor College of Medicine in Houston, where he completed rotations at Houston Methodist Hospital and the University of Texas MD Anderson Cancer Center. In addition, he was honored with the American Society of Hematology Medical Student Award in 2003. Dr. Berilgen went on to complete a radiation oncology residency as well as the Pinnacle Hands-On Intensity-Modulated Radiation Therapy Training Course at the UTMB School of Medicine in Galveston, where he served as Chief Resident in radiation oncology from 2008 to 2009. He then completed further elective training at MD Anderson Cancer Center, where he focused on malignancies of the breast, gastrointestinal (GI) tract and lung. Additionally, Dr. Berilgen trained in pediatric radiation oncology at St. Jude’s Children’s Research Hospital in Memphis, Tenn. Throughout his specialized training, he completed extensive training in 3D conformal radiation therapy, CT/MRI/PET-based simulation, HDR brachytherapy (mammosite, prostate and GYN), IMRT (H&N, Lung, GI and Prostate), and respiratory gating. Board certified in radiation oncology by the American Board of Radiology, Dr. Berilgen specializes in the Calypso GPR Tracking System, image guide radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), RapidArc radiotherapy, stereotactic body radiotherapy (SBRT), stereotactic radiotherapy (SRS) and volumetric arc therapy (VMAT). He previously served as the Medical Director and Comprehensive Cancer Center Director for Sadler Clinic, and now serves as Director of Radiation Oncology for Millennium Physicians. Dr. Berilgen is a member of the American Brachytherapy Society (ABS), the Association Radium Society (ARS), the American Society of Clinical Oncology (ASCO), the American Society of Therapeutic Radiology and Oncology (ASTRO) and the Texas Medical Association (TMA). When he is not practicing medicine, Dr. Berilgen enjoys playing tennis, chess and poker as well as watching independent films.

Dr. Berilgen is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 1 clinical trial. Dr. Berilgen is currently accepting new patients.